We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Sebastian
Fuller
sfuller@sgul.ac.uk
Dr
Sebastian
Fuller
sfuller@sgul.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Infections with a predominantly sexual mode of transmission
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The Facilitators to Adoption study has been designed to identify and investigate key facilitators for adoption of POCTs in sexual health clinics (SHCs) in England through an iterative mixed method (qualitative and quantitative) assessment of stakeholder opinions. This process will help us to understand the social, structural and contextual forces that can facilitate/create barriers to adoption of these novel technologies.
This study is part of a collaboration between Atlas Genetics Ltd., Aquarius Population Health (APH) and St George’s, University of London’s Applied Diagnostic Research and Evaluation Unit (ADREU), under the Innovate UK Small Business Research Initiative (SBRI) grant “Stratified medicine: connecting the UK infrastructure: Phase 2”.
The aims of the grant are to develop a 30-minute multi-pathogen sexually transmitted infection point-of-care test (POCT; Atlas Genetics), and facilitate the clinical adoption of this test. The study covered here will be identifying the facilitators for adoption of the POCT alongside the clinical validation and service evaluation studies. Clinics selected in this programme of work have been chosen to match the needs of both this study and the overall programme of work.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Qualitative;
You can take part if:
You may not be able to take part if:
N/A (Those not fulfilling the inclusion criteria above.)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Sebastian
Fuller
sfuller@sgul.ac.uk
Dr
Sebastian
Fuller
sfuller@sgul.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by St. George's Hospital Medical School and funded by Innovate UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 36108
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
